Adenovirus Infection
📧 Sign up to get email alerts when something new happens for Adenovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/2 trials evaluating injections of CD4+ and CD8+ T cells targeting cytomegalovir…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]
This is a Phase 1 trial update reporting completion of a study evaluating allogeneic multivirus-directed cytotoxic T lymphocytes for Epstein…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]
Phase 2 study evaluating the safety and feasibility of infusing donor-derived virus-specific T cells for post-transplant viral infections in…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation [EARLY_Phase 1]
Clinical trial update on an early-phase adoptive T cell therapy designed to treat adenovirus infection after allogeneic hematopoietic stem c…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation [Phase 3]
A Phase 3 trial evaluating posoleucel (ALVR105) for treating adenovirus infection after allogeneic hematopoietic cell transplantation was te…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reporting completed results for Posoleucel (ALVR105) studied to prevent multiple viral infections after allogeneic hem…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection [Phase 3]
Phase 3 trial evaluating the effectiveness of a single dose of betamethasone in children with symptomatic adenovirus infection.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection [Phase 3]
Phase 3 trial assessing brincidofovir for early versus late adenovirus infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating antigen-specific cytotoxic T cells for treating opportunistic infections including EBV, CMV, adenoviru…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Specific Respiratory Infections as Triggers of Acute Medical Events
A completed clinical trial update examining whether specific respiratory infections act as triggers for acute medical events, including card…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CTL-ADV, clinical-grade adenovirus-specific T cells, as immunotherapy after allogeneic stem cell transpl…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]
This clinical trial update covers Phase 1/2 testing of allogeneic virus-specific cytotoxic T-lymphocytes for adenovirus and Epstein-Barr vir…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus [Phase 1]
A Phase 1 study evaluating safety, toxicity and maximum tolerated dose of a single IV infusion of donor cytotoxic T lymphocytes specific for…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]
Phase 1 trial update on VIRAGE, rapidly generated multivirus-specific cytotoxic T-lymphocytes, for viral infections in the context of stem c…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Collection and Testing of Respiratory Samples
A completed clinical trial assessing collection and testing of respiratory samples using the QIAGEN ResPlex II Advanced Panel and Artus Infl…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children [Phase 2, Phase 3]
This document notes the completed Phase 2/Phase 3 trial of nitazoxanide suspension for diarrhea caused by enteric viruses in children, inclu…